Pilot Study of Behavioural Intervention for Nutrition in Cystic Fibrosis
NCT ID: NCT01957072
Last Updated: 2015-03-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
17 participants
INTERVENTIONAL
2014-02-28
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
It is recommended that adult with CF achieve a BMI of 23 for males and 22 for females. However, fewer than 50% adult with CF achieved that target BMI despite effective nutritional support to help support weight gain. There is a clear need for a behavioural intervention that can help PWCF use the available nutritional support.
This is a feasibility study to try out a multi-component behavioural intervention. The intervention is designed to help PWCF use their nutritional support to gain weight. It will focus on testing the methods and procedures to be used on a larger scale, improving the behavioural intervention and estimating the how many people are needed for the larger trial.
All eligible 75 PWCF in Sheffield will be invited to participate. The investigators anticipate recruiting 30 participants. Participants will be divided into two groups. The first group receive the behavioural intervention immediately. The second group receive the intervention after 3 months. All participants will be followed up for 6 months. Data will be collected every 6 weeks during clinic reviews.
These two groups will be compared against each other to estimate the potential impact of the behavioural intervention. The investigators will also interview some of the participants at the end of the study period to improve the intervention and the study processes based on participant feedback.
The investigators hypothesised that this study will recruit around 30 participants, around 80% of the participants will complete the study, a single full-time investigator can deliver the intervention to 15 participants over 3 months and data collection will be thorough (with less than 5% missing data). The investigators also hypothesised that this feasibility study will help improve the intervention and help the design of a larger trial.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of a Behavioural Intervention Using App Technology in CF
NCT03782909
Remote Exercise to Improve Physical Activity Levels and Markers of Heart Health in Cystic Fibrosis (RHH-CF)
NCT07027553
A Pilot Study of a Low Glycemic Load Diet in Adults With Cystic Fibrosis
NCT04519853
A CFit Study - Baseline
NCT03234387
Effects of a Partially Supervised Conditioning Program in CF
NCT01744561
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Behaviour change intervention
Intensive behaviour change intervention for 3 months, followed by a maintenance phase for 3 months
Behaviour change intervention
The behaviour change intervention consists of
1. feedback via a web-based food diary
2. 'coaching' with problem-solving and implementation plans
The intensive intervention phase consists of 2 home visits, 8 telephone calls and 6 reminder emails.
The maintenance phase consists of 3 telephone calls and 4 reminder emails.
Wait-list Control
Usual care for 3 months, followed by intensive behaviour change intervention for 3 months
Behaviour change intervention
The behaviour change intervention consists of
1. feedback via a web-based food diary
2. 'coaching' with problem-solving and implementation plans
The intensive intervention phase consists of 2 home visits, 8 telephone calls and 6 reminder emails.
The maintenance phase consists of 3 telephone calls and 4 reminder emails.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Behaviour change intervention
The behaviour change intervention consists of
1. feedback via a web-based food diary
2. 'coaching' with problem-solving and implementation plans
The intensive intervention phase consists of 2 home visits, 8 telephone calls and 6 reminder emails.
The maintenance phase consists of 3 telephone calls and 4 reminder emails.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* best BMI of \< 23 for males and \< 22 for females between Oct '12 and Oct '13
Exclusion Criteria
* patients who are pregnant
* patients who have no capacity to consent to participate in the study
* patients who have no IT facilities to use the web-based food diary
* patients who are unable to communicate by telephone for coaching
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sheffield Teaching Hospitals NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martin J Wildman, PhD
Role: PRINCIPAL_INVESTIGATOR
Sheffield Teaching Hospitals NHS Foundation Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust
Sheffield, South Yorkshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRAS Project ID 139047
Identifier Type: OTHER
Identifier Source: secondary_id
STH17327
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.